GOP Senator SLAMS RFK Jr. — Series Of Failures

Senator Bill Cassidy sharply criticized Health Secretary Robert F. Kennedy Jr. for what he called a series of failures at the Department of Health and Human Services, warning that Kennedy’s performance threatens to taint the president’s legacy as healthcare costs rise and public health crises mount.

Measles Crisis And Broken Promises

The Louisiana Republican, who chairs the Senate Committee on Health, Education, Labor and Pensions, pointed to devastating consequences under Kennedy’s leadership. America has lost its measles elimination status, with infants now dying from the disease. Cassidy said mothers who supported Kennedy’s “Make America Healthy Again” movement specifically wanted action on ultra-processed foods, but have seen minimal progress. These supporters, hundreds of whom contacted Cassidy during Kennedy’s confirmation process, now have every right to feel disappointed by the lack of meaningful change.

Kennedy recently declared that the Senate no longer has leverage over him, calling it a big deal and suggesting nothing would stand in his way. Cassidy dismissed this as an attempt to provide cover for Kennedy’s failures as Health Secretary. The senator rejected Kennedy’s logic that Democratic control would somehow make his work easier, calling the claim baseless excuse-making for poor performance.

Impeachment Talk And Presidential Legacy

When asked about impeachment discussions circulating among Democrats, Cassidy acknowledged that impeachment remains technically possible but indicated the focus should be on the president’s decision-making. He argued that rising healthcare costs, the loss of measles elimination status, and stalled progress on food quality issues will ultimately damage the president’s legacy. Cassidy urged the administration to make changes, noting that midterm election results showed voters rejecting the status quo in healthcare.

FDA Nomination In Limbo

The criticism comes as Cassidy’s committee prepares to vote on Heidi Overton’s nomination for FDA commissioner. The senator said he spent the week working phones, consulting with Overton, advisers, and four or five fellow Republican committee members. Despite these discussions, Cassidy said he still has unresolved questions and cannot predict whether Overton’s nomination will advance. The uncertainty surrounding this key position adds another layer of instability to the administration’s healthcare leadership as Kennedy faces mounting criticism from both parties.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Recent

Weekly Wrap

Trending

You may also like...

RELATED ARTICLES